Raleigh capital management firm NovaQuest looks to raise $800M
Raleigh-based NovaQuest Capital Management has raised $90 million in a new fund to invest in biopharmaceutical companies. But that’s not all. It aims to raise $800 million.
Read More
NovaQuest Capital Management
Morrisville life science firm TARGAN raises $35M Series C financing ahead of ‘full commercialization’
Morrisville-headquartered biotechnology firm TARGAN has raised $35 million in Series C funding from new and existing investors.
Read More
Raleigh-based NovaQuest adds $146M haul to its investment fund
NovaQuest Capital Management has raised an additional $146 million for its investment fund, according to a recent SEC filing.
Read More
Mycovia drug shows promise against drug-resistant yeast infection
The developer of drugs in women’s health has shown that its oral drug candidate VT-1598 is active against Candida auris, an emerging multi-drug resistant fungal pathogen that presents a serious global health threat.
Read More
